Ireland - English - HPRA (Health Products Regulatory Authority)

bimeda animal health limited - flunixin meglumine - solution for injection - 50 milligram(s)/millilitre - flunixin

Ireland - English - HPRA (Health Products Regulatory Authority)

cross vetpharm group limited - flunixin - solution for injection - 50 milligram(s)/millilitre - flunixin - cattle, horses, pigs - n.s.a.i.d.

Ireland - English - HPRA (Health Products Regulatory Authority)

cross vetpharm group limited - flunixin - solution for injection - 50 mg/ml - flunixin - bovine, equine - food, porcine - n.s.a.i.d

United States - English - NLM (National Library of Medicine)

bimeda, inc. - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 1 ml - indications horse :  flunazine® injectable solution is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse.  it is also recommended for the alleviation of visceral pain associated with colic in the horse. cattle :  flunazine® injectable solution is indicated for the control of pyrexia associated with bovine respiratory disease, endotoxemia and acute bovine mastitis.  flunazine® injectable solution is also indicated for the control of inflammation in endotoxemia. contraindications horse :  there are no known contraindications to this drug when used as directed.  intra-arterial injection should be avoided.  horses inadvertently injected intra-arterially can show adverse reactions.  signs can be ataxia, incoordination, hyperventilation, hysteria, and muscle weakness.  signs are transient and disappear without antidotal medication within a few minutes.  do not use in horses showing hypersensitivity to flunixin meglumine. cattle :  nsaids inhibit production of prostaglandins which are important in signaling the initiation of parturition. the use of flunixin can delay parturition and prolong labor which may increase the risk of stillbirth. do not use flunazine® injectable solution within 48 hours of expected parturition.  do not use in animals showing hypersensitivity to flunixin meglumine.  use judiciously when renal impairment or gastric ulceration are suspected.

United States - English - NLM (National Library of Medicine)

bimeda, inc. - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - flunixin meglumine 50 mg in 100 ml - indication flunazine-s (flunixin meglumine injection) is indicated for the control of pyrexia associated with swine respiratory disease. contraindications there are no known contraindications to this drug in swine when used as directed. do not use in animals showing hypersensitivity to flunixin meglumine. use judiciously when renal impairment or gastric ulceration is suspected.

United States - English - NLM (National Library of Medicine)

bimeda inc. - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - indications: flunazine equine paste is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. activity: flunixin meglumine is a potent, nonnarcotic, nonsteroidal, analgesic agent with anti-inflammatory and antipyretic activity. it is significantly more potent than pentazocine, meperidine, and codeine as an analgesic in the rat yeast paw test. oral studies in the horse show onset of flunixin activity occurs within 2 hours of administration. peak response occurs between 12 and 16 hours and duration of activity is 24 to 36 hours.

Canada - English - Health Canada

bimeda-mtc animal health inc - flunixin (flunixin meglumine) - solution - 50mg - flunixin (flunixin meglumine) 50mg - cattle; swine (pigs); horses

United States - English - NLM (National Library of Medicine)

mwi - flunixin meglumine (unii: 8y3jk0jw3u) (flunixin - unii:356ib1o400) - indications: prevail equine paste is recommended for the alleviation of inflammation and pain associated with musculoskeletal disorders in the horse. activity: flunixin meglumine is a potent, nonnarcotic, nonsteroidal, analgesic agent with anti-inflammatory and antipyretic activity. it is significantly more potent than pentazocine, meperidine, and codeine as an analgesic in the rat yeast paw test. oral studies in the horse show 1 onset of flunixin activity occurs within 2 hours of administration. peak response occurs between 12 and 16 hours and duration of activity is 24 to 36 hours.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

sun pharmaceutical industries europe b.v. - sumatriptan succinate - solution for injection - 12mg/1ml